IDEXX Laboratories, Inc. (IDXX) Q1 2022 Earnings Results

IDEXX Labs Beats on EPS, Stock Down 5.65%

IDEXX Labs reported a positive surprise on EPS, indicating better-than-expected profitability. However, the stock dropped 5.65% likely due to investor concerns about broader market conditions and the lack of revenue details. The cautious tone from management regarding supply chain issues may have also contributed to the stock's decline.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$2.27	N/A	+0.80%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed confidence in their market position despite external challenges. They emphasized their commitment to growth and innovation.

Management highlighted strong demand in the veterinary market.

They noted ongoing challenges in supply chain but remain focused on innovation.

IDEXX Labs Beats on EPS, Stock Down 5.65%

Key numbers

Management commentary

IDEXX Laboratories, Inc.

More earnings this week

IDEXX Labs Beats on EPS, Stock Down 5.65%

Key numbers

Management commentary